Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NXTC Nextcure Inc.

已收盘 04-29 16:00:00 EDT

8.94

-0.31

-3.35%

盘后8.94

+0.000.00%

19:44 EDT

最高9.21	最低8.66	成交量1.82万
今开9.21	昨收9.25	日振幅5.95%
总市值3,225万	流通市值2,038万	总股本360.76万
成交额16.45万	换手率0.80%	流通股本227.96万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":8.94,"timestamp":1777492800000,"preClose":9.25,"halted":0,"volume":18215,"hourTrading":{"tag":"盘后","latestPrice":8.94,"preClose":8.94,"latestTime":"19:44 EDT","volume":127,"amount":1131.21,"timestamp":1777506268152,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03351351351351357,"floatShares":2279600,"shares":3607555,"eps":-19.646444,"marketStatus":"已收盘","change":-0.31,"latestTime":"04-29 16:00:00 EDT","open":9.21,"high":9.21,"low":8.66,"amount":164487.60667,"amplitude":0.059459,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-19.646444,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777536000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":9.25,"postHourTrading":{"tag":"盘后","latestPrice":8.94,"preClose":8.94,"latestTime":"19:44 EDT","volume":127,"amount":1131.21,"timestamp":1777506268152,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.197904,"impliedVol":0.7756,"impliedVolPercentile":0.9804},"requestUrl":"/m/hq/s/NXTC","defaultTab":"news","newsList":[{"id":"2618909523","title":"Nextcure, Inc.盘中异动 临近收盘急速拉升6.06%报13.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618909523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618909523?lang=zh_cn&edition=full","pubTime":"2026-03-12 03:58","pubTimestamp":1773259100,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日03时58分，Nextcure, Inc.股票出现异动，股价大幅上涨6.06%。截至发稿，该股报13.48美元/股，成交量4.3323万股，换手率1.24%，振幅7.08%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312035820a461f3bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312035820a461f3bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","NXTC","CRC","BK4139","LU0266512127.USD","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616350999","title":"Nextcure, Inc.股价重挫16.82% 市值跌41.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616350999?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:38","pubTimestamp":1772462339,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时38分，Nextcure, Inc.股票出现异动，股价大幅下跌16.82%。截至发稿，该股报10.58美元/股，成交量1234股，换手率0.04%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222390097a7af0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222390097a7af0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0456854461.SGD","LU0266512127.USD","NXTC","BK4213","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608358502","title":"Nextcure, Inc.盘中异动 股价大涨8.33%报11.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608358502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608358502?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:04","pubTimestamp":1770138295,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日01时04分，Nextcure, Inc.股票出现异动，股价快速拉升8.33%。截至发稿，该股报11.84美元/股，成交量1.2307万股，换手率0.35%，振幅4.21%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401045597a4b6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401045597a4b6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","NXTC","CRC","BK4139","LU0266512127.USD","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606132477","title":"Nextcure, Inc.盘中异动 大幅下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606132477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606132477?lang=zh_cn&edition=full","pubTime":"2026-01-28 04:02","pubTimestamp":1769544127,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日04时02分，Nextcure, Inc.股票出现异动，股价急速下跌5.82%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012804020897a3a6f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012804020897a3a6f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","BK4213","BK4139","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603291565","title":"Nextcure, Inc.盘中异动 股价大涨5.46%报14.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603291565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603291565?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:35","pubTimestamp":1768228518,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时35分，Nextcure, Inc.股票出现波动，股价大幅上涨5.46%。截至发稿，该股报14.10美元/股，成交量193股，换手率0.01%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223518a4bb11d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223518a4bb11d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","CRC","LU0266512127.USD","BK4139","BK4213","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595179222","title":"Nextcure, Inc.盘中异动 下午盘急速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595179222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595179222?lang=zh_cn&edition=full","pubTime":"2025-12-30 03:31","pubTimestamp":1767036698,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日03时31分，Nextcure, Inc.股票出现波动，股价急速拉升5.32%。截至发稿，该股报13.45美元/股，成交量1.6169万股，换手率0.46%，振幅5.32%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230033138a4871b8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230033138a4871b8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0266512127.USD","BK4213","BK4139","LU0456854461.SGD","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195873990","title":"NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1195873990","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195873990?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:01","pubTimestamp":1762952473,"startTime":"0","endTime":"0","summary":"NextCure宣布按纳斯达克规则以市场价格进行2150万美元的普通股私募投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518284977","title":"Nextcure, Inc.2024财年实现净利润-55.65百万美元，同比增加11.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518284977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518284977?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536082,"startTime":"0","endTime":"0","summary":"3月10日，Nextcure, Inc.公布财报，公告显示公司2024财年净利润为-55.65百万美元，同比增加11.27%；其中营业收入为0.00美元，每股基本收益为-1.99美元。从资产负债表来看，Nextcure, Inc.总负债16.45百万美元，其中短期债务796000.00美元，资产负债比为4.98，流动比率为7.51。机构评级：截至2025年3月10日，当前有2家机构对Nextcure, Inc.目标价做出预测，其中目标均价为3.00美元，其中最低目标价为3.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000304a2689894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000304a2689894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517145291","title":"NextCure(NXTC.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.41美元，前值为-0.52美元，预期值为-0.36美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145291","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517145291?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301839,"startTime":"0","endTime":"0","summary":"NextCure(NXTC.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.41美元，前值为-0.52美元，预期值为-0.36美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113678994","title":"NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)","url":"https://stock-news.laohu8.com/highlight/detail?id=1113678994","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113678994?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:19","pubTimestamp":1741295952,"startTime":"0","endTime":"0","summary":"NextCure（NASDAQ:NXTC）报告季度每股亏损$(1.99)，低于分析师一致预期$(1.92)，差幅为3.65%。以上内容来自Benzinga Earnings专栏，原文如下：NextCure (NASDAQ:NXTC) reported quarterly losses of $(1.99) per share which missed the analyst consensus estimate of $(1.92) by 3.65 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NextCure 2024财年GAAP每股收益$(1.99)不及预期$(1.92)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517167564","title":"Nextcure, Inc.盘中异动 早盘大幅上涨5.41%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517167564?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277091,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分，Nextcure, Inc.股票出现异动，股价快速上涨5.41%。截至发稿，该股报0.780美元/股，成交量2.2204万股，换手率0.08%，振幅4.36%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000451abeb8e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","LU0266512127.USD","CRC","NXTC","BK4139","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517943623","title":"Nextcure, Inc.盘中异动 大幅拉升5.53%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943623?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186149,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Nextcure, Inc.股票出现波动，股价急速上涨5.53%。截至发稿，该股报0.780美元/股，成交量770股，换手率0.00%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224909963ae0f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","BK4213","LU0266512127.USD","LU0456854461.SGD","BK4139","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517067216","title":"Nextcure, Inc.盘中异动 快速下跌7.98%报0.671美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517067216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517067216?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:09","pubTimestamp":1741104554,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时09分，Nextcure, Inc.股票出现波动，股价大幅下跌7.98%。截至发稿，该股报0.671美元/股，成交量1.0797万股，换手率0.04%，振幅5.49%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030500091496395e97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030500091496395e97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","LU0456854461.SGD","BK4139","LU0266512127.USD","NXTC","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516668245","title":"Nextcure, Inc.盘中异动 下午盘股价大跌6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668245?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:31","pubTimestamp":1741030270,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时31分，Nextcure, Inc.股票出现异动，股价大幅下跌6.41%。截至发稿，该股报0.729美元/股，成交量6210股，换手率0.02%，振幅4.49%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033111989a519e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033111989a519e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","NXTC","BK4139","BK4213","CRC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514200733","title":"Nextcure, Inc.盘中异动 股价大跌8.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514200733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514200733?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:33","pubTimestamp":1740753228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，Nextcure, Inc.股票出现异动，股价大幅下挫8.74%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223349963419e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223349963419e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0266512127.USD","BK4213","BK4139","LU0456854461.SGD","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513472061","title":"Nextcure, Inc.盘中异动 早盘大幅拉升6.38%报0.769美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513472061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513472061?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:00","pubTimestamp":1740409211,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时00分，Nextcure, Inc.股票出现波动，股价快速拉升6.38%。截至发稿，该股报0.769美元/股，成交量3473股，换手率0.01%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242300129890fcec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242300129890fcec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","BK4139","CRC","BK4213","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512486933","title":"Nextcure, Inc.盘中异动 早盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512486933?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:50","pubTimestamp":1739976648,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时50分，Nextcure, Inc.股票出现异动，股价急速上涨6.43%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225048a24bfe41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225048a24bfe41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NXTC","BK4213","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511469675","title":"Nextcure, Inc.盘中异动 早盘快速上涨5.84%报0.767美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511469675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511469675?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:46","pubTimestamp":1739544364,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时46分，Nextcure, Inc.股票出现异动，股价大幅拉升5.84%。截至发稿，该股报0.767美元/股，成交量1490股，换手率0.01%，振幅3.51%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224605abcf09d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224605abcf09d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRC","LU0266512127.USD","BK4139","NXTC","BK4213","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525725","title":"Nextcure, Inc.盘中异动 早盘快速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525725?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457133,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Nextcure, Inc.股票出现波动，股价快速下跌5.17%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132232139621bbf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132232139621bbf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NXTC","BK4213","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510805563","title":"Nextcure, Inc.盘中异动 股价大涨8.32%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510805563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510805563?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分，Nextcure, Inc.股票出现异动，股价大幅上涨8.32%。截至发稿，该股报0.800美元/股，成交量1972股，换手率0.01%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235059881bd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235059881bd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","NXTC","BK4139","LU0456854461.SGD","LU0266512127.USD","BK4213","CRC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nextcure.com","stockEarnings":[{"period":"1week","weight":-0.1568},{"period":"1month","weight":-0.0759},{"period":"3month","weight":-0.1355},{"period":"6month","weight":-0.2449},{"period":"1year","weight":0.6584},{"period":"ytd","weight":-0.3481}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.1224},{"period":"3month","weight":0.0234},{"period":"6month","weight":0.0469},{"period":"1year","weight":0.292},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NextCure, Inc.于2015年9月在特拉华州注册成立，总部位于马里兰州贝尔茨维尔。 该公司是一家临床阶段的生物制药公司，致力于发现和开发新型的一流免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。 通过其专有的功能性，集成式，免疫肿瘤学中的NextCure Discovery（“FIND-IO”）平台，公司研究各种免疫细胞，以发现和了解免疫细胞的靶标和结构成分及其功能影响，从而开发免疫组化。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.02663},{"month":2,"riseRate":0.285714,"avgChangeRate":0.046168},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.077039},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.142199},{"month":5,"riseRate":0.5,"avgChangeRate":0.044182},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.038185},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.066636},{"month":8,"riseRate":0.571429,"avgChangeRate":0.058864},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085295},{"month":10,"riseRate":0.428571,"avgChangeRate":0.136079},{"month":11,"riseRate":0.571429,"avgChangeRate":0.061609},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.021792}],"exchange":"NASDAQ","name":"Nextcure Inc.","nameEN":"Nextcure Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nextcure Inc.,NXTC,Nextcure Inc.股票,Nextcure Inc.股票老虎,Nextcure Inc.股票老虎国际,Nextcure Inc.行情,Nextcure Inc.股票行情,Nextcure Inc.股价,Nextcure Inc.股市,Nextcure Inc.股票价格,Nextcure Inc.股票交易,Nextcure Inc.股票购买,Nextcure Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nextcure Inc.(NXTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nextcure Inc.(NXTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}